Protego Ventures Closes $125M Debut Defense Tech Fund

TL;DR: Protego Ventures closed its debut fund at $125 million, per TechCrunch. Led by Lital Leshem and Lee Moser, the fund writes $5M–$15M checks into Israeli defense tech. I care less about the total than the $25 million they turned down — a concentration bet on drone maker XTEND that most GPs wouldn't make.

What happened

Protego Ventures closed its debut fund at $125 million in capital commitments, TechCrunch reported after learning of the close exclusively. Lital Leshem and Lee Moser started the firm as a dedicated defense tech venture fund focused on Israel. That fund size lets Protego write checks of $5 million to $15 million per company — a range built for early-growth companies with a working product, not seed-stage teams pitching a deck.

Leshem and Moser were encouraged to start the firm in the aftermath of the October 7, 2023 Hamas attack on Israel, on the conviction that new technology would be central to the country's defense, according to the same report. That's the origin story. The real story is what they did with the last $25 million of their target — they walked away from it.

Why Protego raised less than its target, on purpose

Protego set out to raise $150 million and stopped at $125 million. That's not a fundraising miss. The firm made a deliberate call, per the report: "a smaller fund magnifies the impact of a single big win on overall returns," and with portfolio company XTEND now looking like a potential fund-returner, raising more capital would have diluted that upside among a bigger pool of LPs.

Downside first: a fund manager turning down committed capital to protect concentration is the opposite of what most sponsors do. Most funds max out every dollar they can raise, because management fees scale with fund size. Protego chose smaller AUM over bigger fees, protecting the return profile for the LPs already in.

I've spent years vetting sponsors, and I've been burned trusting people who could tell me exactly what they closed but never what they turned down. That's the alignment signal I look for before I write a check into any fund, defense tech or otherwise: ask a GP what they said no to, not just what they raised.

What Protego actually invests in

Protego describes itself as an early-growth-stage investor across defense-specific categories: sensors, AI and machine learning, and autonomous systems including drones and unmanned aerial vehicles, according to the firm's own site. Its highest-profile position is XTEND, a drone and autonomous-systems company that went public on the New York Stock Exchange this month. A report from Mezha also names ASIO, a situational-awareness systems developer that works with Anduril, as a portfolio company.

XTEND going public while still inside Protego's active portfolio is the detail that makes the "stopped short on purpose" decision make sense. A liquidity event inside a concentrated portfolio moves the whole return curve harder than it would in a fund spread across a hundred names. Verify before you trust the framing, though: the "fund maker" language describes Protego's own thesis, not a realized return. XTEND trading publicly is not the same as XTEND having returned Protego's fund.

How do I get exposure to a fund like this?

You don't, not directly. Protego is a $125 million institutional fund with LP minimums built for family offices, defense-focused funds-of-funds, and large allocators, not a $25,000 angel check. If defense tech is on your radar as an accredited investor, the actionable move isn't chasing this specific fund. It's borrowing Protego's own framework as the checklist you apply to any specialist fund, syndicate, or SPV that does take individual checks: what did the GP turn down, and why.

That's the piece of this story an individual investor can use, whether or not a dollar of Protego's $125 million ever touches your portfolio.

The broader signal: defense tech VC is not a niche anymore

Defense tech venture dealmaking set a record in the first quarter of 2026, and new VC firms have formed globally to invest solely in defense startups, according to the same TechCrunch report. Protego is one data point in that pattern. If you've followed Stark Defence's European raise, Mach Industries' recent round, or Lakestar's Resilience I fund, Protego fits the same shape: specialist capital chasing a category institutional generalist funds spent a decade avoiding.

Here's what Protego's own numbers show, and nothing beyond them:

Fund metric	Protego Ventures (debut fund)
Target raise	$150 million
Final close	$125 million
Check size per company	$5 million–$15 million
Implied portfolio size	Roughly 8 to 25 companies

That range is simple division, not a projection: a $125 million fund at $5–15 million checks lands somewhere between 8 and 25 positions, depending how Protego sizes each one.

Common mistakes when reading a fund-close headline

Investors new to this category assume a "$125 million fund" behaves like a $125 million check into one company. It doesn't. That capital gets deployed across the roughly 8 to 25 companies shown above.

A second mistake is assuming every defense tech fund invests at the same stage. Protego is explicit that it backs early-growth companies with proven technology, not pre-seed teams with a pitch deck. Confirm the stage before you compare two funds on size alone.

What to watch next

Protego is already preparing a second fund, planned to launch in the first quarter of 2027, according to a report from Mezha. I'd watch two things: whether XTEND's public performance validates the "fund maker" thesis once actual returns replace the pitch, and whether Protego keeps the same size discipline on its next fund once it has a marked win to point to. Discipline is easy to claim on a debut fund. It's harder to keep once a firm has proof it works.

FAQ

How much did Protego Ventures raise for its debut fund? $125 million in capital commitments, according to TechCrunch's exclusive reporting on the final close.

Why didn't Protego hit its $150 million target? It stopped on purpose, see "Why Protego raised less than its target" above. A smaller fund concentrates the payoff from a single strong outcome like XTEND.

What kind of companies does Protego invest in? Early-growth defense technology companies across sensors, AI and machine learning, and autonomous systems such as drones and UAVs, per the firm's own site.

What is XTEND and why does it matter to this fund? XTEND is a portfolio company that makes autonomous drone systems and recently went public on the New York Stock Exchange, according to a report from Mezha. TechCrunch describes it as a potential fund maker for Protego, a single investment that could return the whole fund.

Is this part of a bigger trend in venture capital? Yes. Defense tech VC dealmaking set a record in the first quarter of 2026, with new specialist firms forming globally to invest solely in the category, per TechCrunch.

One thing to do today

If you're an LP or angel evaluating any specialist fund, ask the GP directly what they turned down and why, the way Protego did with its extra $25 million. Access is not an edge. Judgment is, and that one question tells you more about a sponsor's alignment than the pitch deck does. Want more due-diligence checklists like this one before the next fund close crosses your desk? That's what the AIN briefing is for.

Educational content only. Not investment, tax, or legal advice. Not an offer or solicitation to buy or sell securities. Past performance does not guarantee future results. Private-market investments are illiquid and involve risk of loss, including total loss of capital. Consult qualified advisers. Angel Investors Network is not a broker-dealer or investment adviser.